The fluorescence of cyclin A binding peptide was quenched by energy transfer and electron-transfer processes but displayed fluorescence enhancement upon recognition and binding of cyclin A. This strategy demonstrated a nanomolar limit of detection of cyclin A and was thus proposed as a prognostic indicator of early stage cancer (Wang et al., 2010). This evidence concerns the gene CCNA2 and cancer.